Allstate Corporation’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$593K Sell
15,580
-30,059
-66% -$1.27M 0.01% 767
2026
Q2
$2.15M Buy
45,639
+273
+0.6% +$6.75K 0.02% 452
2026
Q1
$857K Buy
+45,366
New +$770K 0.01% 858

Other funds holding DFTX

Allstate Corporation's DFTX Position: Q3 2026 in Review

Allstate Corporation reduced its Definium Therapeutics (DFTX) stake by 66% in Q3 2026, selling an estimated $1.27M and leaving 15,580 shares worth $593K. The position accounts for 0.01% of the portfolio, ranked #767.

Allstate Corporation first reported a position in DFTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.15M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Allstate Corporation held 15,580 shares of Definium Therapeutics worth $593K as of Q3 2026.
  • Allstate Corporation sold 30,059 Definium Therapeutics shares in Q3 2026, an estimated $1.27M.
  • Definium Therapeutics made up 0.01% of Allstate Corporation's portfolio in Q3 2026, its #767 holding.
  • Allstate Corporation first reported a position in Definium Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Allstate Corporation's Definium Therapeutics position peaked at $2.15M in Q2 2026.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Allstate Corporation's 13F filing for Q3 2026, filed 16 Nov 2026.